Kelfred Holdings Limited
1134.HK
HKD0.325 67.53%
Exchange: HKSE | Sector: Healthcare | Industry: Medical Instruments Supplies
Q2 2025
Published: Jun 30, 2025

Earnings Highlights

  • Revenue of $242.52M up 89.4% year-over-year
  • EPS of $-0.01 increased by 0% from previous year
  • Gross margin of 12.9%
  • Net income of -4.72M
  • "" -

Kelfred Holdings Limited (1134.HK) QQ2 2025 Financial Results β€” Eyewear OEM/ODM Growth Amid Revenue Upside and Profitability Trim

Executive Summary

Kelfred Holdings Limited reported QQ2 2025 revenue of HKD 242.524 million, delivering a robust YoY growth of 89.35% but posting a net loss of HKD 4.717 million and a negative operating margin of 0.77%. The quarter featured an EBITDA of HKD 5.163 million and positive operating cash flow of HKD 2.969 million, underscoring a business in the early stages of scale where top-line momentum outpaces near-term profitability. The balance sheet remains liquidity favorable with HKD 29.586 million in cash and negative net debt (HKD -20.505 million), supporting continued investment in design, ODM capabilities, and market expansion. Valuation metrics suggest the stock trades at modest multiples relative to earnings and sales (P/B ~0.62; P/S ~0.40), reflecting the current earnings trajectory and growth potential embedded in the eyewear segment. Management commentary, where available, emphasized ongoing product development and geographic expansion, though no formal full-year guidance was disclosed in QQ2 2025. Investors should weigh the improving revenue trajectory and strong liquidity against the current profitability gap and the need for operating leverage to translate growth into sustained earnings.

Key Performance Indicators

Revenue

242.52M
QoQ: 0.00% | YoY:89.35%

Gross Profit

31.21M
12.87% margin
QoQ: 0.00% | YoY:132.25%

Operating Income

-1.87M
QoQ: 0.00% | YoY:52.14%

Net Income

-4.72M
QoQ: 0.00% | YoY:-0.55%

EPS

-0.01
QoQ: 0.00% | YoY:0.00%

Revenue Trend

Margin Analysis

Key Insights

Key QQ2 2025 metrics and trends (HKD). Revenue: HKD 242,524,000, YoY +89.35%, QoQ +0.00%. Gross profit: HKD 31,211,000, Gross margin 12.87%, YoY +132.25%, QoQ +0.00%. Operating income: HKD -1,871,000, Operating margin -0.77%, YoY +52.14%, QoQ +0.00%. Net income: HKD -4,717,000, Net margin -1.94%, YoY -0.55%, QoQ +0.00%. EBITDA: HKD 5,163,000, EBITDA margin 2.13%. EPS: HKD -0.0094. Cash from operations: HKD 2,969,500; Free cash flow: HKD 2,534,500. Capex: HKD -435,000. Cash balance: HKD 29,586,00...

Historical Earnings Comparison

PeriodRevenue ($M)EPS ($)YoY GrowthReport
Q2 2025 242.52 -0.01 +89.4% View
Q1 2025 121.26 0.00 +22.9% View
Q4 2024 128.08 -0.01 +29.3% View
Q3 2024 128.08 -0.01 +29.3% View